CI

At a glance

ClinicalIndex Comparison Record
Phase 1Recruiting· 28 target
Drug / intervention
Temozolomide +8 moredrug
Likely dose
Not stated in record
Key inclusion· 7
  • Age ≥18 years
  • Primary high-grade glioma (WHO grade III-IV, including glioblastoma), IDH and MGMT status independent
  • Prior biopsy confirming high-grade glioma eligible
  • Planned neurosurgical resection of tumor
Key exclusion· 11
  • Pregnant women
  • Nursing women unwilling to cease during therapy
  • Men or women of childbearing potential unwilling to use adequate contraception
  • Prior history of cranial radiotherapy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05030298
NCT05030298Phase 1RecruitingHigh MomentumUpdated 2mo ago
Long Recruiting

Preoperative Radiosurgery in High Grade Glioma: A Phase I Clinical Trial: The NeoGlioma Study

Mayo Clinic·interventional·Posted Sep 1, 2021·Updated Apr 22, 2026

In Brief

A Phase 1 clinical trial evaluating Radiation Therapy, Radiosurgery, and 7 other interventions for Malignant Glioma. Currently recruiting, targeting 28 participants across 2 sites.

Signals

Enrolling ahead of pace

Detailed Summary

This phase I trial finds out the possible benefits and/or side effects of radiosurgery before surgery (preoperative) in treating patients with high grade glioma. Radiosurgery uses special equipment to position the patient and precisely give a single large dose of radiation to the tumor. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving pre-operative radiosurgery may improve the odds of brain tumor control and reduce treatment-related side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1Recruiting
202220232024202520262027
First PostedSep 1, 2021
Enrollment StartMay 23, 2023
Primary CompletionSep 15, 2027
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 4.8 years agoPrimary completion in 1.2 years

Interventions

Radiation Therapyradiation

Undergo radiation therapy

Radiosurgeryradiation

Undergo radiosurgery

Stereotactic Biopsyprocedure

Undergo MRI-guided stereotactic biopsy

Temozolomidedrug

Drug

Tumor Treating Fields Therapyprocedure

Undergo TTF

Magnetic Resonance Imagingprocedure

Undergo MRI

Biospecimen Collectionprocedure

Undergo blood sample collection

Biopsyprocedure

Undergo biopsy

Therapeutic Conventional Surgeryprocedure

Undergo surgery